The ELEVATE Study shows that atogepant effectively prevents episodic migraine.

Published Date: 24 Apr 2023

Atogepant (Qulipta) performed better than a placebo in the ELEVATE study for preventing episodic migraine in patients who were resistant to other treatments.

Read Full News

Latest News

What is Causing This MS Patient's Unusual Symptoms?

Gait problems, twitching, and "strange sensations" atypical of multiple sclerosis

This Unusual Syndrome of the Face Could Be an Early Sign of AML

Case started with severe pain and numbness

New Autism Committee Chair Founded a Leucovorin Telehealth Company

Drug has been promoted as a treatment for autism

Possible Drug-Drug Interactions Flagged for Older Americans

— Many are on 5+ prescription drugs or dietary supplements

A Dementia Vaccine? Most Americans Say Yes

— Nearly three-fourths of people 50 or older said they'd get vaccinated if they were at high risk

Years of Progressing Facial Numbness and Deteriorating Vision Drives Diagnosis

Suspect perineural recurrence of cutaneous squamous cell carcinoma, experts urge

Todays Updates

ASTRO: American Society for Radiation Oncology

Todays Updates

ASTRO: American Society for Radiation Oncology

Latest News

Gait problems, twitching, and "strange sensations" atypical of multiple sclerosis

Case started with severe pain and numbness

Drug has been promoted as a treatment for autism

— Many are on 5+ prescription drugs or dietary supplements

— Nearly three-fourths of people 50 or older said they'd get vaccinated if they were at high risk

Suspect perineural recurrence of cutaneous squamous cell carcinoma, experts urge

News All Time

More NFL Players Have CTE Than Previously Thought, Study Suggests

At least 1 in 4 pro players who died from 2016 to 2021 had the progressive brain disorder

Federal Committee Looks Backward as Autism Science Moves Forward

In its second meeting, federal autism committee advances plan that may stymie promising research

New Migraine Prevention Guidance Highlights CGRP Drugs, Broad Eligibility

Guidelines from AAN and AHS get first update since 2012

Will Patient Deaths Derail the CAR-T Train in Autoimmune Disease?

Novartis, BMS reportedly halt trials; first serious blow to burgeoning field

Alzheimer's Genetic Risk; Underreported Dementia; Exercise or Nap After Sleep Loss?

News and commentary from the world of neurology and neuroscience

Study: Chronic Pain May Really Be 'All in Your Head'

Protein from skull bone marrow appears to play a key role

Autism-Vaccine Researcher Says He Stole $1M in CDC Grant Funds

Extradited Danish physician admits guilt in operating wire fraud scheme

Is Paxlovid Any Better Than Placebo for Long COVID?

In three major symptom phenotypes, randomized trial finds no benefit

1,081 Injuries Tied to Device; Military's COVID Shot Probe; Teen Vax Coverage Slides

Health news and commentary gathered by MedPage Today staff

Rare Brain Disorder Gets Its First FDA Drug Approval

Zilganersen targets protein buildup that drives Alexander disease

Parkinson's Risk and Carbon Monoxide: What a New Study Found

Analysis offers surprising twist to the smoking-Parkinson's puzzle

Iron, Selenium, and Dementia; Epilepsy and Education; Brain Death Conversations

News and commentary from the world of neurology and neuroscience

MS Drugs Differ Most on Relapses, Not Disability, Real-World Study Shows

In new patients, disability score changes were similar over 2 years regardless of treatment

Autism Tied to 14-Year Gap in Life Expectancy

Large U.S. study points to preventable causes of excess mortality

Trial Confirms IVIG as Useful Therapy for Inflammatory Myopathy

But thromboembolic risks could be significant

First Therapy to Target Muscle Loss in Spinal Muscular Atrophy Gets FDA Approval

Motor function may improve with adjunctive apitegromab

Recommended News For You

Surgery may not be necessary to treat invasive breast cancer

Major Shifts in Urothelial Cancer Care: Immunotherapy Redefines Standards

AI Unlocks Benefits of Prostate Cancer Treatment.

New tumor therapy approach reduces costs and side effects while increasing accessibility

Low-Dose Radiation Provides Almost Perfect Control Over Slow-Growing Lymphoma.

Cardiopulmonary fitness is key for helping breast cancer patients manage post-diagnosis symptoms, say researchers

Genomic Newborn Screening Could Identify Childhood Cancer Predisposition

Recommended Articles For You

Pharmacokinetic Variability in Hematologic Disorders: Mechanisms, Clinical Implications, and Evidence-Based Approaches 

Building Bridges between Heart and Cancer Care: A Comprehensive Guide to Cardio-Oncology Clinics 

Clinical Methods in Hematology and Quality Improvement 

AI-Assisted Real-Time Tumor Mapping During Surgery: Transforming Intraoperative Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A video animation guide to assist young people who are fatigued from cancer.

2.

Cabozantinib Improves PFS for Advanced Neuroendocrine Tumors

3.

Aspirin Fails to Boost Survival in Colorectal Cancer Trial

4.

AI Framework Helps Classify Renal Tumors, Predict Outcomes

5.

NEJM: Pirtobrutinib is effective in CLL patients who have received prior BTK inhibitor therapy.

1.

Spatially Guided Tumor Margin Navigation Technologies: A Comprehensive Medical Review

2.

Secure Computational Infrastructure for Collaborative Multicenter Oncology Research Without Centralizing Patient Data

3.

Segmental vs. Non-Segmental Vitiligo: What’s the Difference?

4.

Building Physical Resilience in Chronic Blood Disorders

5.

Surgery for Tracheoesophageal Fistula: What to Expect Before, During, and After 

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV

2.

The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.

3.

Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment

4.

Navigating the Complexities of Ph Negative ALL - Part XIII

5.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot